Two new telehealth businesses aim to siphon popular services from office-based primary care practices. LetsGetChecked, which bills itself as a "healthcare solutions" company, just received FDA approval for an at-home
gonorrhea and chlamydia test that uses a urine sample collected by the patient and mailed to a lab. The test is $99, and for $50 more, patients can add trichomoniasis, along with HIV and syphilis performed on blood collected from a finger prick. After patients mail their specimens in, results are delivered in 2 - 5 days, and appropriate infections can be treated over telehealth for $39. At-home hepatitis B and C, herpes, vaginitis (using a vaginal swab), male and female hormones, and thyroid testing are also available.
The other new competitor is drug manufacturer Eli Lilly, which is now offering LillyDirect, a service where they connect consumers with telehealth doctors who can prescribe Eli Lilly medications for diabetes, migraines, and weight loss, including the popular Zepbound. Eli Lilly then ships the drug directly to the patient. LillyDirect also accepts prescriptions from other providers, essentially serving as a mail-order pharmacy for Eli Lilly products.
Primary care providers know that STD screening requests are common - and often obsessive - so there is little doubt LetsGetChecked will be a popular service. Eli Lilly wading into direct-to-consumer care will be interesting to watch, particularly in the obesity drug category.